Therapeutic effects of psilocybin in treatment of anxiety and depression | Roland Griffiths
The use of psychedelic drugs in the 1960s prompted the United States government to assign these drugs Schedule I status, the most controlled drugs under federal regulation. According to the Controlled Substances Act, they have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use of the drug or other substance under medical supervision. This status effectively halted the clinical research being conducted on these drugs. However, in the past 20 years, new, well-designed trials have demonstrated that these drugs elicit mystical experiences in the user that may have sustained, beneficial effects, especially in people who have depression. In this clip, Dr. Roland Griffiths describes the current state of research on psychedelic drugs.
Member support keeps us strong.
If you enjoy the fruits of , you can participate in helping us to keep improving it. Creating a pay-what-you-can subscription does just that! Plus, we throw in occasional member perks and, more importantly, churn out the best possible content without concerning ourselves with the wishes of any dark overlords.
Our website is 100% supported by people like you through this pay-what-you-can mechanism.
Fundamentals$15 / month
Loyal Fan$25 / month
Super Fan$50 / month
Power Supporter$125 / month
Heroic Supporter$250 / month